Our Team

Zone Labs was founded by Dr. Barry Sears in 1999. Dr. Sears is a highly regarded research scientist who has authored over 50 scientific publications. In addition, he has written 19 books that have sold more than six million copies in the U.S. and have been translated into more than 20 languages. He has 14 U.S. patents in areas ranging from cancer drug delivery, the treatment of cardiovascular disease, and the invention of the lipids used in the only approved nanotechnology cancer drug and the current mRNA vaccines for treating COVID-19.

<p>DR. BARRY SEARS, PRESIDENT</p>

Dr. Saha is one of the leading authorities in metabolic research and a leading expert in AMPK, the master regulator of metabolism. He was previously an Associate Professor at the Boston University School of Medicine and has over 100 scientific publications.

<p>DR. ASISH SAHA, CHIEF SCIENTIFIC DIRECTOR</p>

Mary Perry is a registered dietician and has a master’s degree in nutrition. She serves as the Director of Clinical Trials at Zone Labs and coordinates all clinical trials using Metabolic EngineeringTM. Before joining Zone Labs, she was aresearch dietician at Harvard Medical School. Mary has four scientific publications with Dr. Sears.

<p>MARY PERRY, DIRECTOR OF CLINICAL TRIALS</p>

Charles Serhan is one of the world’s leading researcher on the role of resolvins in the reduction of resolution of inflammation. He is the Simon Gelman Professor of Anesthesia at the Harvard Medical School and director of the Center of Experimental Therapeutics and Reperfusion Injury at the Brigham and Women’s Hospital. He received the International Eicosanoid Research Foundation’s Lifetime Achievement Award in 2017. He has authored over 500 scientific publications, written five books, and awarded over 200 patents.

<p>Dr. Charles Serhan, Harvard Medical School</p>

Camillo Ricordi is one of the world’s leaders in cell transplantation to treat type 1 diabetes. He is the Stacy Joy Good man Professor of Surgery, Distinguished Professor of medicine, and Professor of biomedical engineering, microbiology, and immunology. He serves as scientific director and chief academic officer of the University of Miami Diabetes Research Institute. He was appointed to Italy’s Supreme Council of Health in 2019. He has authored over 1,170 scientific publications, been awarded 28 patents, and is the author The Healthspan Code published in 2022.

<p>Dr. Camillo Ricordi, University of Miami Medical School</p>

Carol Johnston is a professor of Nutrition at Arizona State University and director of the Nutrition Program. She is a leading expert in functional foods. She received the Grace Goldsmith ward for significant achievements in nutrition by a scientist under 50 years, sponsored by the American College of Nutrition in 2004, and the Mark Bieber Professional Award, sponsored by the American College of Nutrition for academic accomplishments in 2008. Her research areas include vitamin C and dietary interventions in obesity and diabetes. She has more than 100 scientific publications.

<p>Dr. Carol Johnston, Arizona State University</p>
Because of our biotechnology background, we hold our products to higher standards. Today’s consumer demands more information to make an informed buying decision. Our products are produced for the customer who demands continuing testing of the potency and purity of the products they are consuming. This is why we pioneered the concept of consumer confidence by posting the post-production testing of every lot of omega-3 and polyphenol supplements on our website. Furthermore, our omega-3 fatty acids and polyphenol supplements (OmegaRx®, MaquiRx®, and CacacoRx®) have Generally Regarded as Safe (GRAS) status, meaning they can be incorporated into food products. Such GRAS status is possible only if you have done significant toxicology studies on the safety of that supplement, which then must be affirmed by an outside expert review panel. This is what you would expect from a biotechnology company.